Aug 18, 2021 ProMIS Neurosciences Inc. Announces Upsize of Previously Announced Public Offering of Units to US$17.5M
Jul 22, 2021 ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference
Jun 8, 2021 ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease